Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.
about
Are we there yet? The smallpox research agenda using variola virusChallenges for Australia's Bio/Nanopharma Policies: trade deals, public goods and reference pricing in sustainable industrial renewalThe Future of Smallpox Vaccination: is MVA the key?The Microbial Rosetta Stone Database: a compilation of global and emerging infectious microorganisms and bioterrorist threat agentsSynthetic biology and biosecurity: challenging the "myths"Cytokine production associated with smallpox vaccine responsesGeneral considerations on the biosafety of virus-derived vectors used in gene therapy and vaccinationThe evolution of poxvirus vaccinesDeficiency in Th2 cytokine responses exacerbate orthopoxvirus infectionEvidence-Based Biosafety: a Review of the Principles and Effectiveness of Microbiological Containment MeasuresPoxvirus tropismA Hippocratic Oath for life scientists. A Hippocratic-style oath in the life sciences could help to educate researchers about the dangers of dual-use researchThe Unilateralist's Curse and the Case for a Principle of ConformityData sharing and dual-use issuesBetween Scylla and Charybdis: reconciling competing data management demands in the life sciencesWhy has Not There been More Research of Concern?Synthetic constructs in/for the environment: managing the interplay between natural and engineered BiologyGain-of-Function Research: Ethical Analysis.[Lessons learnt from the German smallpox outbreaks after World War II].Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein.A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: a novel strategy for immune evasionCreation of killer poxvirus could have been predictedNational-level biosafety norms needed for dual-use research.Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate.Antipodal biosecurity? Oversight of dual use research in the United States and australia.Electron microscopy for rapid diagnosis of infectious agents in emergent situationsAdvances in life sciences and bioterrorism. Risks, perspectives and responsibilities.Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.Ocular infection of mice with an avirulent recombinant HSV-1 expressing IL-4 and an attenuated HSV-1 strain generates virulent recombinants in vivo.The dual-use problem, scientific isolationism and the division of moral labour.A stimulating way to improve T cell responses to poxvirus-vectored vaccinesPoxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses.Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.Cell-mediated cytotoxicity in recovery from poxvirus infections.Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity.The potential for abuse of genetics in militarily significant biological weapons.Hope and ambition turn to dismay and neglect: the Biological and Toxin Weapons Convention in 2001.
P2860
Q21131362-A54F03FB-BA67-4A69-8834-6CE7E476C288Q24670636-3249AF4A-21EB-4BFE-A9C6-A94639E7773BQ24801195-DF502277-3E3F-437E-8B03-076F6B4FB9C0Q24804488-CB6EA4A3-075F-4B87-BD54-520E2D68944BQ24810427-BA157C0F-D506-463B-A215-1C359C1E66DFQ26823501-1CCB84D6-DFF8-4211-9F7A-BB20DF9FF94FQ26850701-623D54B3-3456-4497-BCA8-6A91A1F045ECQ26995905-D5FE24FE-CB15-4FB5-9022-78E518C5471EQ27313373-AD7DC9C9-8839-417A-8A55-2101FBA1DEC3Q27486575-44E5E398-86A4-4E9C-9F21-B79A9D020D43Q28237434-228B191C-5953-4679-AA33-ED92AC5BE2DAQ28250271-C2467B9D-F27C-479A-824E-38455A17FE77Q28595938-01D098E6-0D43-4F90-A20A-D0522C0BBEA7Q28601984-045BEAB4-2DA6-42CE-AD07-0BF9C3829276Q28602672-96D5D4EA-FFBF-4B89-B637-3574FFC4A9A5Q28655459-508D189D-CD77-4B2E-98D7-3D7EF17DA543Q28729206-B540909E-E774-4A7F-8FC7-673709670AC4Q30151855-E483F19D-63B4-4C5A-B33E-9B7E7750B785Q30203443-109EB45E-E52C-49DC-80A0-E814AB63463AQ33755146-DC8AF14A-A4F0-4F62-B294-5A6D99FBC1FAQ33769393-AA7AC15E-396F-445C-9D73-CCB2D00F781EQ33843114-A2F23626-33D7-49C2-BEAB-0E4D3E102387Q33853781-FE8338F4-BC49-4EF2-8F08-4B7DDD7EC57CQ33891459-66C0152D-17E4-4B94-A20C-A4E05D5C720AQ33908872-F22BDC6F-2D3B-4C77-B64D-BC0F669D4E23Q34017475-1B4F899A-770F-4F6B-AA36-1565281BEE02Q34192904-4E6E657D-7375-4FA3-B895-5E5AE0C4D32AQ34219176-0D2D7ED7-2D02-467F-A696-A1B09BEB0AFBQ34250677-8F2B984A-49C0-49D2-A764-6418AADF6C20Q34357917-30F7E4D9-6A70-4FA3-8F9E-1EC1A6C33C86Q34364070-7C2E312B-FEFC-45F3-B735-55CAF6BBCE4FQ34411097-904806B0-BBB5-42F5-B60E-CED911B854CEQ34429078-F0C80AB5-B3DC-4C88-A112-59A23927D36DQ34432037-2F49A03D-C243-4C5D-8F09-BD7E8AD16B7BQ34479840-4A04AE86-669F-4617-860A-0806AF2769DDQ34504791-D64D4796-A7F1-4491-9DE3-B55106D1C6E3Q34534717-8FD36156-0736-4797-A0D9-A3892C25A745Q34576972-0F549EA8-3625-4D79-B87F-208A42C8D32BQ34666048-56DDAE16-4012-4D85-81D2-2320F58415FBQ34666061-58A56DEB-6340-4459-950C-533FFB28F098
P2860
Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Expression of mouse interleuki ...... enetic resistance to mousepox.
@ast
Expression of mouse interleuki ...... enetic resistance to mousepox.
@en
type
label
Expression of mouse interleuki ...... enetic resistance to mousepox.
@ast
Expression of mouse interleuki ...... enetic resistance to mousepox.
@en
prefLabel
Expression of mouse interleuki ...... enetic resistance to mousepox.
@ast
Expression of mouse interleuki ...... enetic resistance to mousepox.
@en
P2093
P2860
P1433
P1476
Expression of mouse interleuki ...... genetic resistance to mousepox
@en
P2093
A J Ramsay
C D Christensen
I A Ramshaw
P2860
P304
P356
10.1128/JVI.75.3.1205-1210.2001
P577
2001-02-01T00:00:00Z